BI 1002494, a Novel Potent and Selective Oral Spleen Tyrosine Kinase Inhibitor, Displays Differential Potency in Human Basophils and B Cells.
about
BI 1002494, a Novel Potent and Selective Oral Spleen Tyrosine Kinase Inhibitor, Displays Differential Potency in Human Basophils and B Cells.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
BI 1002494, a Novel Potent and ...... n Human Basophils and B Cells.
@en
BI 1002494, a Novel Potent and ...... n Human Basophils and B Cells.
@nl
type
label
BI 1002494, a Novel Potent and ...... n Human Basophils and B Cells.
@en
BI 1002494, a Novel Potent and ...... n Human Basophils and B Cells.
@nl
prefLabel
BI 1002494, a Novel Potent and ...... n Human Basophils and B Cells.
@en
BI 1002494, a Novel Potent and ...... n Human Basophils and B Cells.
@nl
P2093
P2860
P356
P1476
BI 1002494, a Novel Potent and ...... in Human Basophils and B Cells
@en
P2093
Andreas Schnapp
Bernd Guilliard
Christine Strasser
Daniel Bischoff
David J Lamb
Della White
Eva Thaler
Georg Rast
Gerd-Michael Maier
P2860
P304
P356
10.1124/JPET.116.233155
P407
P577
2016-04-05T00:00:00Z